Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,291 across all filing types
Latest filing 2018-11-19 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
前次募集资金使用情况鉴证报告
Regulatory Filings
2018-11-19 Chinese
公开发行A股可转换公司债券预案
Capital/Financing Update Classification · 100% confidence The document is a detailed proposal for a public issuance of A-share convertible corporate bonds by Zhengzhou Antu Biological Engineering Co., Ltd. It includes extensive information about the issuance plan, terms, conditions, financial data, and management discussion. The document is lengthy (15,000 characters) and contains substantive financial statements and detailed descriptions of the financing activity. It is not a brief announcement or a certification letter but a comprehensive disclosure related to capital raising through convertible bonds. Therefore, it fits the category of Capital/Financing Update (CAP).
2018-11-19 Chinese
关于公司公开发行A股可转换公司债券募集资金使用可行性分析报告
Capital/Financing Update Classification · 95% confidence The document is a detailed feasibility analysis report regarding the use of funds raised from a public issuance of A-share convertible bonds by Zhengzhou Antu Bioengineering Co., Ltd. It includes extensive information on the investment projects, policy and market background, company background, project necessity, feasibility, and economic benefits. The content focuses on capital raising and the planned use of proceeds for expansion and R&D projects. There is no indication that this is an annual report, earnings release, or other financial statement. Instead, it is a capital/financing update related to a convertible bond issuance and the use of the raised funds. The document length is over 11,000 characters, so it is not a mere announcement of a report but a substantive report on financing and capital use. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2018-11-19 Chinese
未来三年股东回报规划（2018-2020年）
Regulatory Filings Classification · 85% confidence The document is titled '未来三年股东回报规划（2018-2020年）' which translates to 'Future Three-Year Shareholder Return Plan (2018-2020)'. It discusses the company's profit distribution policy, cash dividend plans, and shareholder return strategy over a multi-year period. It references regulatory guidelines from the China Securities Regulatory Commission regarding cash dividends and outlines principles and conditions for profit distribution. The document is a detailed plan or policy statement about shareholder returns rather than an announcement of dividend amounts, voting results, or a financial report. It does not contain financial statements or earnings data, nor is it a regulatory filing or announcement of a report publication. It is a strategic plan document related to shareholder returns and dividend policy. This fits best under the category of Notice of Dividend Amount (DIV) or possibly a Regulatory Filing (RNS). However, since it is a detailed plan about dividend policy and shareholder returns rather than a simple dividend amount announcement, and given the lack of actual dividend payment details, the closest classification is Regulatory Filings (RNS) as a fallback for miscellaneous filings that do not fit other categories. The document length is short (1617 characters), and it is not a report publication announcement. Therefore, the best fit is Regulatory Filings (RNS).
2018-11-19 Chinese
可转换公司债券持有人会议规则
Governance Information Classification · 95% confidence The document is titled as rules for the convertible bondholders' meeting of Zhengzhou Antu Bioengineering Co., Ltd. It details the organization, rights, obligations, meeting procedures, voting rules, and legal framework for bondholders' meetings related to convertible bonds issued by the company. It references relevant laws and regulatory bodies such as the China Securities Regulatory Commission and Shanghai Stock Exchange. The content is a governance document specifically about bondholder meetings and their rules, not a financial report, announcement, or other filing types. It is a detailed governance-related document outlining internal rules and procedures for bondholder meetings, which fits the Governance Information (CGR) category best.
2018-11-19 Chinese
关于最近五年未被证券监管部门和证券交易所采取监管措施或处罚情况的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Zhengzhou Antu Bioengineering Co., Ltd. stating that in the past five years, the company has not been subject to any regulatory measures or penalties by securities regulatory authorities or stock exchanges. It is related to the company's intention to apply for public issuance of convertible bonds. The document is brief (392 characters) and serves as a regulatory compliance statement rather than a detailed report or financial statement. It does not contain financial data, management changes, or voting results. It fits best as a Regulatory Filing (RNS) because it is a compliance-related announcement that does not fit other specific categories.
2018-11-19 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.